Back to calendar
Cartesian Therapeutics, Inc. (RNAC) Earnings
RNAC reports earnings on Thursday, August 6, 2026
earnings report
August 6, 2026
Q2 2026
Est. EPS: $-1.01
Actual EPS: $0.46
EPS surprise: 152.40%
Company overview
Market Cap$260.2M
PriceUSD 8.60
EPS (TTM)-5.94
52-week high11.80
52-week low5.60
SectorHealth Technology
IndustryBiotechnology
Employees75